290
Letters to the Editor Roy Homburg1 Barzilai Medical Centre, Ashkelon, Israel 1
Correspondence address: E-mail:
[email protected] doi:10.1093/humrep/dep330 Advanced Access publication on October 24, 2009
patients were seen from 1984 to 1999, prior to the introduction of Onco-TESE in our centre. I agree with the absolute necessity to introduce testicular sperm extraction in the management of fertility preservation when patients failed to provide a semen sample, or when azoospermia is discovered. However, this proposition should not be limited to testicular cancer but to the situations of cancer treatment at very high risk of testicular irreversible damage.
References Reply: Fertility preservation in adolescent males: experience over 22 years at Rouen University Hospital
Nathalie Rives1 EA 4308, ‘Spermatogene`se et qualite´ du game`te male’, IFRMP23, IHU Rouen Normandie, Laboratoire de Biologie de la Reproduction, CECOS, CHU Hoˆpitaux de Rouen, CHU Charles Nicolle, 76031 Rouen, France 1
Correspondence address. Tel: þ33-2-32-88-82-25; Fax: þ33-2-35-98-20-07; E-mail:
[email protected] doi:10.1093/humrep/dep331 Advanced Access publication on October 24, 2009
Downloaded from http://humrep.oxfordjournals.org/ by guest on January 21, 2016
Sir, Menon et al. (2009) report a population of 156 adolescents who cryopreserved sperm at Rouen University Hospital over 22 years. Only 18 patients (11.5%) were unable to provide a sample, and not 40% as indicated by Carmignani et al. Most of our patients who failed to provide a sample had cancer and not specifically testicular cancer. Onco-TESE was performed in only five patients because the remaining
Menon S, Rives N, Mousset-Sime´on N, Sibert L, Vannier JP, Mazurier S, Masse´ L, Duchesne V, Mace´ B. Fertility preservation in adolescent males: experience over 22 years at Rouen University Hospital. Hum Reprod 2009;24:37 – 44.
